Dataset Information


A novel class of alternative 3’-terminal exons is involved in cell-cycle regulation by topoisomerase inhibitors

ABSTRACT: Alternative 3’-terminal exons, which use intronic polyadenylation sites, are generally unconserved and lowly expressed, while the main gene products end in the last exon of genes. In this study, we discover a class of human genes, where the last exon appeared recently during evolution, and the major gene product uses an alternative 3’-terminal exon corresponding to the ancestral last exon of the gene. This novel class of alternative 3’-terminal exons are down-regulated on a large scale by doxorubicin, a cytostatic drug targeting topoisomerase II, and play a role in cell cycle regulation, including centromere-kinetochore assembly. The RNA-binding protein, HuR/ELAVL1 is a major regulator of this specific set of alternative 3’-terminal exons. HuR binding to the alternative 3’-terminal exon in the pre-messenger RNA promotes its splicing, and is reduced by topoisomerase inhibitors. These findings provide new insights into the evolution, function and molecular regulation of alternative 3’-terminal exons. 6 samples of MCF7 cells exposed to different treatments were analyzed: 3 x control_6 hours; 3 x doxorubicin_6 hours.

ORGANISM(S): Homo sapiens  

SUBMITTER: Fatima Zahra Chakrama   Micaela Polay Espinoza  Martin Dutertre  Emmanuel Combe  François-Olivier Desmet  Didier Auboeuf  Lise Gratadou  Hussein Mortada 

PROVIDER: E-GEOD-53474 | ArrayExpress | 2014-02-04



Similar Datasets

2011-05-05 | E-GEOD-26341 | ArrayExpress
2013-09-06 | E-GEOD-47032 | ArrayExpress
2011-06-10 | E-GEOD-27501 | ArrayExpress
2011-11-28 | E-GEOD-32998 | ArrayExpress
2015-11-01 | E-GEOD-52244 | ArrayExpress
2012-08-01 | E-GEOD-36542 | ArrayExpress
2011-02-01 | E-GEOD-26463 | ArrayExpress
2015-12-31 | E-GEOD-73439 | ArrayExpress
2013-06-15 | E-GEOD-47945 | ArrayExpress
2014-08-13 | E-GEOD-42690 | ArrayExpress